🇺🇸 High intensity statin plus ezetimibe therapy in United States

High intensity statin plus ezetimibe therapy (High intensity statin plus ezetimibe therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

High intensity statin plus ezetimibe therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is High intensity statin plus ezetimibe therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for High intensity statin plus ezetimibe therapy in United States?

Samsung Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.